Objectives

Apart from financial success, our goal is to provide our clients, poultry farmers, an efficient, cost-effective, easy-to-use and safe tool to combat E. coli and Salmonella, an alternative or compliment to the currently used antibiotics which are gradually phased out due to the concern with antimicrobial resistance (AMR) rise.

Consequently, bacteriophages are currently the most promising answer to this global health and safety problem. PHAGOVET will be a major step towards an effective solution and as a result, we will significantly enhance the EU health safety.

This new solution will allow consortium partners ALS-CONTROLVET, VETWORKS and PHAGE CONSULTANTS to penetrate a new lucrative niche market (EU countries and China, USA and Brazil, top poultry meat producers in the world) while consolidating their position in the Animal Health, Food Safety and Environmental Control markets (more than €26.4 million accumulated revenues for 2022-2026 period).